[Form 4] KFORCE INC Insider Trading Activity
David M. Kelly, Chief Operating Officer of Kforce Inc. (KFRC), reported receipt of 679 additional shares of common stock on 09/12/2025 under a dividend issuance described as exempt from Rule 16a reporting. The filing states the issuer declared a cash dividend of $0.39 per share on 07/25/2025, payable 09/26/2025 to shareholders of record on 09/12/2025, and that the additional shares are restricted and will vest per existing restricted stock agreements. Following the transaction, Mr. Kelly beneficially owns 95,862 shares, including 53,768 restricted shares. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
- Transparent disclosure of the dividend-related share issuance and post-transaction beneficial ownership
- Quantified post-transaction holdings: 95,862 shares, including 53,768 restricted shares
- Dividend details provided: $0.39 per share declared on 07/25/2025, payable 09/26/2025, record date 09/12/2025
- None.
Insights
TL;DR: Insider received a small, non-cash dividend in restricted shares, modestly increasing ownership to 95,862 shares.
The reported transaction is a dividend-in-kind resulting in 679 restricted shares issued at no cash cost to the insider, tied to a $0.39 per-share cash dividend declaration. This is a routine equity-compensation and dividend mechanics disclosure rather than an arms-length purchase or sale. The increase in beneficial ownership is clear but appears modest given the absolute share count; the restricted nature of a material portion of holdings suggests continued alignment with company incentives.
TL;DR: Disclosure documents a standard dividend-related issuance to an officer with restricted-share vesting terms.
The Form 4 appropriately discloses a dividend-exempt issuance under Rule 16a and quantifies post-transaction ownership, including 53,768 restricted shares. The use of an attorney-in-fact signature is noted and acceptable when properly authorized. No trading or sale activity is reported; the filing documents compensation-related equity treatment and meets Form 4 reporting requirements.